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Sjogren’s syndrome is one of the most common autoimmune 
diseases. It may exist as either a primary syndrome or as a secondary 
syndrome associated with other autoimmune diseases such as 
rheumatoid arthritis and systemic sclerosis. Patient with Sjogren’s 
syndrome have certain visual system involvements with dry eye 
being the most common type. These patients may also exhibit 
certain pathological changes in their retina and visual pathway.
Here we report the electrophysiological recordings including visual 
evoked potential, electroretinography and electrooculography 
findings in a patient with Sjogren’s syndrome. 
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Introduction
Sjogren’s syndrome (SS) is an autoimmune 
disease. In this disease the immune system 
attacks tears and saliva glands causing dry 
eyes and dry mouth 1. While SS was once 
considered a rare disease, it is now considered 
the second most common autoimmune disease 
after rheumatoid arthritis. Its prevalence is 
estimated at 1 % (0.1-4.8 %), with an incidence 
of 7 per 100,000 in the United States 1. The 
true prevalence of SS is hard to determine 
because of the frequent changes in diagnostic 
criteria. Variation in the method of diagnosis 
might be caused by the training of the clinician 
making the diagnosis (ophthalmologist, 
oral surgeon, rheumatologist, internist) and 
inclusion of markers that are potentially more 
sensitive.  Visual system is among the organs 
which might be involved in patients with SS. 
The principal ocular manifestation is decreased 
tear production leading to chronic irritation 
2. Along with decreased tear production and 
subsequent corneal damage these patients may 
also exhibit some pathological changes in 
their retina.
Jack et al., 3 in 2015 performed a study on 
retina of nine SS patients (5 male, 4 females; 
age range 3-23 years). All patients exhibited 
photophobia and macular crystals. Retinal 
pigment epithelium (RPE) atrophy was present 
in 10 of 18 eyes. Also the full retinal thickness 
was reduced by 22 %, the inner nuclear layer 
was reduced by 30 % and the outer nuclear 
layer was reduced by 40 % 3. This thinning 
suggests that there is outer retinal injury in 
SS, which could be the result of direct toxicity, 
loss of trophic factors, or altered development. 
Dysfunction of various sensory pathways may 
be also present in SS patients 4,7.
Hydroxychloroquine (HCQ) is frequently 
used to treat primary SS 8, and the incidence 
of retinopathy among patients using this 
antimalarial medication is relatively high 9. 
Therefore, electrophysiological examination 
of visual system including electroretinography 
(ERG), electrooculography (EOG) and visual 
evoked potential (VEP) are performed in SS 
patients prior to HCQ administration and the 
use of HCQ should be avoided in presence of 
retinopathy.
Here we report the electrophysiological 
recordings including visual evoked potential, 
electroretinography and electrooculography 
findings in a patient with Sjogren’s syndrome. 
Case report
A fifty-six years old lady with SS was 
referred to Basir Eye Clinic, Tehran, Iran, for 
electroretinography and electrooculography 
examination. She claimed that her disease 
was not diagnosed in time and after several 
examinations of her organs, finally a dentist 
suspected the Sjogren’s syndrome due to 
certain characteristic changes of her teeth. Her 
dentist referred the patient to a rheumatologist 
for further evaluation and  the rheumatologist 
confirmed the diagnosis of SS.  She had also 
consulted with an ophthalmologist several 
times due to dry eyes, for which artificial tears 
had been prescribed.
Her best corrected visual acuity at admission 
was 10/10 and she had normal fundus. 
The rheumatologist had decided to start 
hydroxychloroquine (HCQ) treatment, for 
which ocular examination was necessary, so 
the patient was referred to our center. 
In our center the ophthalmologist ordered 
ERG and EOG examinations. The 
electrophysiologist decided to perform visual 
evoked potential (VEP) exam beside these 
two ordered examinations. Both ERG and 
EOG were subnormal, but the VEP findings 
were normal. Regarding the ERG, b wave 
amplitude was reduced to less than 50% of 
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normal value (Right eye voltage 45 μv, left 
eye voltage 32 μv). The normal value for ERG 
b wave amplitude is above 100 μv. Regarding 
the latency of b wave in ERG, the values 
obtained were in normal range (Right eye 42 
μv, left eye 44 μv). In EOG the Arden Index 
(AI) values obtained were 1.62 and 1.38 for 
right and left eyes respectively. The normal 
value for AI is 1.80 to 2.80.
Discussion 
The ERG and EOG were subnormal in our 
patient. It is a well-known fact that the retina 
of SS patients might be affected, and ERG and 
EOG can screen for the degeneration produced 
in different layers of retina.  Changes in 
different layers of retina have been previously 
reported among SS patients 3,10.  In a study 
by Willemsen et al., 11 including fifteen SS 
patients no changes in EOG and ERG were 
reported, which is in contradiction with our 
findings. 
Another electrophysiological technique which 
was used in our evaluation was visual evoked 
potential (VEP). The result was normal and the 
visual pathway was not affected in our patient. 
Sekaric et al., 12 have reported a 52-year-old 
woman suffering from SS with normal VEP, 
which is similar to our results, but in a study 
reporting an Indian family in 2009, the two 
siblings with SS were found to have abnormal 
visual evoked potentials 7.
Conclusion  
Retinopathy and visual pathway disturbances 
among SS patients are relatively frequent, 
therefore evaluation of electrophysiological 
findings before treatment initiation and close 
follow up monitoring in patients receiving 
hydroxychloroquine is recommended.
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